The effect of supplementation of omega-3 and zinc on the treatment of type 2 diabetes

Phase 3

• Conditions: Type 2 diabetes.; Diabetes mellitus

• Registration Number: IRCT20170214032571N9
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Age range over 18 years old in both sexes
Type 2 diabetes

Exclusion Criteria

Insulin injection
Pregnancy and lactation
Pancreatic cancer
Severe physical activity during the intervention

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Weight. Timepoint: At weeks 0, 8. Method of measurement: Scale, Kg.;Body mass index. Timepoint: At weeks 0, 8. Method of measurement: Weight(kg) / Height(m)².;Insulin resistance. Timepoint: At weeks 0, 8. Method of measurement: (fasting serum glucose (mmol/L) × fasting serum insulin (µIU/ml))/22.5.;Fasting Blood Sugar. Timepoint: At weeks 0, 8. Method of measurement: Enzymatic method, mg/dl.;Quantitative Insulin Sensitivity Check Index. Timepoint: At weeks 0, 8. Method of measurement: 1/ [ log(fasting insulin, µU/ml) + log (fasting glucose, mg/dl) ].;Serum insulin. Timepoint: At weeks 0, 8. Method of measurement: Radioimmunoassay.;Serum zinc. Timepoint: At weeks 0, 8. Method of measurement: Colorimetric.;Systolic blood pressure. Timepoint: At weeks 0, 8. Method of measurement: Mercury pressure gauge, Mm mercury.;Diastolic blood pressure. Timepoint: At weeks 0, 8. Method of measurement: Mercury pressure gauge, Mm mercury.